BioSpace News Archive

Centrexion Therapeutics Corporation announced that Nick Harvey has been appointed Chief Financial Officer of the company.

Dividend to be Paid on September 17, 2018

Xencor, Inc. announced that it will release second quarter 2018 financial results after the market closes on Monday, August 6, 2018.

Increases of around 2.6% for Proton Therapy and 2.9% for Gamma Knife Proposed

Parties File to Dismiss Remaining Claims - Boston Scientific Represents It Has No Plans to Launch High Frequency Product

ABK Biomedical, Inc., a company dedicated to the research, development and commercialization of innovative embolic therapies, has announced the appointment of Michael J. Mangano as president and chief executive officer.

BioAmber Inc. (OTCPK: BIOAQ) announces that the current stage of the Sales and Investor Solicitation Process (SISP) has concluded without an acceptable offer having been received from a Qualified Bidder as of the due date of July 27, 2018.

Acadia PharmaceuticalsInc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the second quarter ended June 30, 2018 on Wednesday, August 8, 2018, after the U.S. financial markets close.

The Greater Bloomington Chamber of Commerce recognized Jeana Finlinson of Cook Group, as one of the 2018 10 Under 40 Awards recipients.

Boston Scientific Corporation is scheduled to participate in the 38th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston.